Minprog (Alprostadil)

Alprostadil, the active ingredient in Minprog, is a prostaglandin E1 analog presented as an injectable solution for intravenous use. It induces smooth‑muscle relaxation and vasodilation, and is employed in specific vascular conditions such as neonatal ductus arteriosus maintenance and peripheral arterial disease. GNH USA supplies Minprog as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Alprostadil acts as a vasodilator in several vascular‑related conditions. - Neonatal ductus arteriosus patency: maintains an open ductus in newborns with certain congenital heart defects. - Peripheral arterial disease: improves blood flow in patients with critical limb ischemia. - Erectile dysfunction (off‑label): facilitates penile erection when other therapies are unsuitable.

Alprostadil may cause a range of adverse reactions, most of which are dose‑dependent and related to its vasodilatory properties.

Common Side Effects: - Hypotension: transient drop in blood pressure. - Flushing: warmth and redness of the skin. - Headache: mild to moderate intensity. - Nausea: occasional upset stomach. - Dizziness: sensation of light‑headedness. - Injection‑site pain: discomfort at the site of administration.

Serious or Rare Side Effects: - Severe hypotension: marked blood‑pressure decline requiring medical attention. - Myocardial infarction: rare cardiac event. - Pulmonary edema: fluid accumulation in lungs. - Allergic reaction: rash, itching, or anaphylaxis. - Priapism: prolonged erection when used for erectile dysfunction. - Penile fibrosis: tissue scarring with prolonged use.

Before initiating Alprostadil therapy, clinicians should assess patient‑specific risk factors and monitor for potential complications. - Cardiovascular assessment: evaluate for unstable angina or recent myocardial infarction. - Bleeding risk: monitor patients receiving anticoagulants or antiplatelet agents. - Renal/hepatic impairment: consider closer observation in patients with organ dysfunction. - Pregnancy and lactation: use only if clearly needed, after risk‑benefit evaluation. - Drug interactions: avoid concomitant use with other potent vasodilators. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Alprostadil can interact with several drug classes, altering its safety profile or efficacy.

Major Interactions (Avoid): - Other vasodilators (e.g., nitroglycerin): may cause severe hypotension. - Phosphodiesterase‑5 inhibitors: can lead to profound blood‑pressure drop. - Anticoagulants: may increase bleeding risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt the vasodilatory response. - Diuretics: can augment hypotensive effects. - Alcohol: may increase dizziness and low‑blood‑pressure episodes.